Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects

Fengping Dong1, Joanna Jiang1, Colleen McSweeney1

  • 1Department of Biology, Pennsylvania State University, University Park, PA 16802, USA.

Insights

Loss-of-function mutations in beta-catenin (CTNNB1) impact neurodevelopment. Deleting CTNNB1 in specific brain cells caused autistic-like behaviors and altered cognitive functions in mice.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Mutations in beta-catenin (CTNNB1) are linked to various disorders, including intellectual disability and autism spectrum disorder (ASD).
  • CTNNB1 is crucial for the canonical Wnt pathway and neurodevelopment, but its role in specific neuronal subtypes remains unclear.

Purpose of the Study:

  • To investigate the cell type-specific function of CTNNB1 in neurodevelopment and its contribution to ASD.
  • To understand how CTNNB1 deficiency in parvalbumin interneurons affects cognitive and behavioral phenotypes.

Main Methods:

  • Generation of CTNNB1 conditional knockout (cKO) mice specifically in parvalbumin (PV)-expressing interneurons.
  • Behavioral analyses including anxiety, motor function, object recognition, social interaction, repetitive behaviors, and spatial memory tests.
  • Assessment of neuronal activity using c-Fos expression in different brain regions.

Main Results:

  • CTNNB1 cKO mice exhibited increased anxiety, impaired object recognition, social interaction deficits, and elevated repetitive behaviors, mimicking core ASD symptoms.
  • Spatial memory was unexpectedly enhanced in CTNNB1 cKO mice.
  • Reduced c-Fos expression was observed in the cortex, but not the dentate gyrus or amygdala, indicating altered neuronal activity.

Conclusions:

  • CTNNB1 plays a cell type-specific role in regulating cognitive functions and autistic-like behaviors.
  • These findings highlight the importance of CTNNB1 in inhibitory circuitry and neurodevelopment.
  • The study offers potential therapeutic targets for ASDs associated with CTNNB1 or Wnt pathway mutations.

Related Concept Videos